Virus and transplantation : proceedings of the twenty-third international course, Lyon, 3-5 June 1991
著者
書誌事項
Virus and transplantation : proceedings of the twenty-third international course, Lyon, 3-5 June 1991
（Symposia Fondation Mérieux, 17 . Transplantation and clinical immunology; 23）
Excepta Medica , Sole distributors for the USA and Canada, Elsevier Science Pub. Co., 1991
- : acid-free pap.
大学図書館所蔵 件 / 全2件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and index
内容説明・目次
目次
I. EPIDEMIOLOGY AND IMMUNOLOGY Epidemiology of virus infections after transplantation (M. Ho). Immune mechanisms controlling viral infections in immuno-comprized hosts (J.M. Dupuy, J.P. Revillard). Processing of viral antigens and their recognition by T cells (S.L. Fuller-Espie). II. VIRAL HEPATITIS Frequency and severity of hepatitis B virus (HBV) recurrence following liver transplantation. Does prophylaxis help? (F. Zoulim, T. Bizollon, C. Trepo). Liver transplantation for fulminant viral hepatitis (M. Sirodot et al.). Liver transplantation for chronic viral liver disease (D. Samuel et al.). Prevalence and aspects of chronic hepatitis during hemodialysis and renal transplantation (A. Hadengue, F. Degos). In kidney graft recipients chronically infected with HBV. The expression of low level replication, wild type and variants may be influenced by immunosuppression (P. Chossegros et al.). HBs antigen positive organ donors and anti-VHC positive organ donors in renal transplantation (F.C. Berthoux et al.). Anti hepatitis C virus antibodies: Prevalence and morbidity in renal transplantation (C. Pouteil-Noble et al.). III. CYTOMEGALOVIRUS The biology of cytomegalovirus (J.E. Grundy). Cytomegalovirus and the immune system (B. Charpentier et al.). Cytomegalovirus infection and rejection in renal transplantation (C. Pouteil-Noble et al.). The influence of HLA A B DR matching on CMV disease after renal transplantation (G. Blancho et al.). Type of immunosuppresssion and CMV infections after kidney transplantation (Y. Vanrenterghem et al.). CMV disease in orthotopic liver transplantation (J.P. Miguet et al.). Cytomegalovirus infection in pulmonary transplantation (J.-F. Mornex et al.). Cytomegalovirus and heart graft failure (O. Bastien et al.). New methods for diagnosis of cytomegalovirus infections (M. Aymard, J.J. Chomel). Prevention and treatment of CMV infection after allogeneic bone marrow transplant (E. Gluckman et al.). Progress of therapies in cytomegalovirus infection (R. Vasquez). (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (HPMPC), a potent and selective inhibitor of cytomegalovirus infection in vitro and in vivo (R. Snoeck, E. De Clerck). Intravenous immunoglobulin for prophylaxis and treatment in allograft recipients (E.C. Reed). The prevention of cytomegalovirus disease in transplantation (C.L. Davis). Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant: A controlled trial (S.A. Plotkin et al.). Economic aspects of cytomegalovirus infections in renal transplant recipients: The cost of cytomegalovirus hyper-immune globulin in Canada (E. Rossier, H. Miller, S. McGuire). IV. OTHER VIRUSES HIV infection in renal transplant patients (P. Lang, P. Niaudet and the groupe Cooperatif de Transplantation de l'Ile de France). Epstein-Barr virus infection after transplantation (M. Ho). Epstein-Barr virus-induced lymphoproliferative disorders in SCID/hu chimeric mice (J.L. Garnier et al.).
「Nielsen BookData」 より